Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Principles of reproducible metabolite profiling of enriched lymphocytes in tumors and ascites from human ovarian cancer

    Identifying metabolites and delineating their immune-regulatory contribution in the tumor microenvironment is an area of intense study. Interrogating metabolites and metabolic networks among immune cell subset...

    Marisa K. Kilgour, Sarah MacPherson, Lauren G. Zacharias, Jodi LeBlanc in Nature Protocols (2022)

  2. Article

    Open Access

    The different prognostic significance of polysialic acid and CD56 expression in tumor cells and lymphocytes identified in breast cancer

    Protein glycosylation, the attachment of carbohydrates onto proteins, is a fundamental process that alters the biological activity of proteins. Changes to glycosylation states are associated with many forms of...

    Sepideh Soukhtehzari, Richard B. Berish, Ladan Fazli, Peter H. Watson in npj Breast Cancer (2022)

  3. Article

    Open Access

    Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers

    Ovarian carcinoma is the most lethal gynecological malignancy due to early dissemination and acquired resistance to platinum-based chemotherapy. Reliable markers that are independent and complementary to clini...

    Cécile Le Page, Kurosh Rahimi, Martin Köbel, Patricia N. Tonin in BMC Cancer (2018)

  4. Article

    Open Access

    Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer

    Infiltration of breast tumors by tumor-infiltrating lymphocytes (TIL) has been associated with sensitivity to anthracycline-based chemotherapy. However, it is unclear whether this is true within the estrogen r...

    Nathan R West, Katy Milne, Pauline T Truong, Nicol Macpherson in Breast Cancer Research (2011)

  5. Article

    Estrogen Receptor Alpha Phosphorylated at Tyrosine 537 is Associated with Poor Clinical Outcome in Breast Cancer Patients Treated with Tamoxifen

    A phospho-tyrosine 537-ERα (p-Y537-ERα) antibody was validated for immunohistochemistry of formalin-fixed paraffin-embedded human breast cancer biopsies and used to interrogate multiple ER positive breast canc...

    Georgios P. Skliris, Zoann Nugent, Peter H. Watson, Leigh C. Murphy in Hormones and Cancer (2010)

  6. No Access

    Article

    Density of tumour stroma is correlated to outcome after adoptive transfer of CD4+ and CD8+ T cells in a murine mammary carcinoma model

    Adoptive immunotherapy shows promise for the treatment of cancer; however, partial or mixed responses remain common outcomes due to the heterogeneity of tumours. We studied three murine mammary tumour lines th...

    Michele L. Martin, Erika M. Wall, Emily Sandwith in Breast Cancer Research and Treatment (2010)

  7. No Access

    Article

    Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor α (ERα) in tissue microarrays of ERα positive human breast carcinomas

    Estrogen receptor α (ERα) activity is regulated by phosphorylation at several sites. Recently several antibodies specific for individual phosphorylated sites within ERα have became available. Such antibodies p...

    George P. Skliris, Brian G. Rowan in Breast Cancer Research and Treatment (2009)

  8. Article

    Open Access

    Evolutionary concepts in biobanking - the BC BioLibrary

    Medical research to improve health care faces a major problem in the relatively limited availability of adequately annotated and collected biospecimens. This limitation is creating a growing gap between the pa...

    Peter H Watson, Janet E Wilson-McManus in Journal of Translational Medicine (2009)

  9. No Access

    Article

    Mammary tumors with diverse immunological phenotypes show differing sensitivity to adoptively transferred CD8+ T cells lacking the Cbl-b gene

    We tested the efficacy of CD8+ T cells lacking the Cbl-b gene against a panel of mammary tumor lines with different intrinsic sensitivities to T cells. Mice bearing established tumors expressing an ovalbumin-tagg...

    Taimei Yang, Michele L. Martin, Julie S. Nielsen in Cancer Immunology, Immunotherapy (2009)

  10. Article

    Open Access

    Steroid Receptor RNA Activator Protein (SRAP): a potential new prognostic marker for estrogen receptor-positive/node-negative/younger breast cancer patients

    The steroid receptor RNA activator is a functional RNA suspected to participate in the mechanisms underlying breast tumor progression. This RNA is also able to encode for a protein, Steroid Receptor RNA Activa...

    Yi Yan, George P Skliris, Carla Penner in Breast Cancer Research (2009)

  11. No Access

    Article

    Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype

    In the present study we investigated the protein expression of claudins 1, 3, and 4 and their relationship to clinical variables and outcome in a cohort of ER−ve and ER+ve human invasive breast cancers. Immuno...

    Anne A. Blanchard, George P. Skliris, Peter H. Watson, Leigh C. Murphy in Virchows Archiv (2009)

  12. Article

    Open Access

    Jab1 is a target of EGFR signaling in ERα-negative breast cancer

    c-Jun activation domain-binding protein-1 (Jab1) is a multifunctional signaling protein that previously has been shown to be a master regulator of a poor prognostic gene signature in invasive breast cancer and...

    Jiaxu Wang, Rebecca O Barnes, Nathan R West, Melanie Olson in Breast Cancer Research (2008)

  13. No Access

    Article

    Estrogen receptor-β regulates psoriasin (S100A7) in human breast cancer

    We have previously observed a paradoxical relationship of the psoriasin/S100A7 gene with estrogen response in-vitro in ERα positive cells but its association with ERα negative status in-vivo raising the possib...

    George P. Skliris, Anthony Lewis, Ethan Emberley in Breast Cancer Research and Treatment (2007)

  14. No Access

    Article

    Assessment of multiple different estrogen receptor-β antibodies for their ability to immunoprecipitate under chromatin immunoprecipitation conditions

    Several different antibodies to total estrogen receptor (ER)β, ERβ1 and ERβ2/cx have been tested and compared for their ability to immunoprecipitate ERβ specific isoforms under chromatin immunoprecipitation co...

    Gregory E. Weitsman, George Skliris, Kanyarat Ung in Breast Cancer Research and Treatment (2006)

  15. Article

    Open Access

    Real-time PCR complements immunohistochemistry in the determination of HER-2/neu status in breast cancer

    The clinical benefit of determining the status of HER-2/neu amplification in breast cancer patients is well accepted. Although immunohistochemistry (IHC) is the most frequently used method to assess the over-expr...

    Andreea Nistor, Peter H Watson, Norman Pettigrew, Karim Tabiti in BMC Clinical Pathology (2006)

  16. No Access

    Protocol

    Breast Tissue Banking

    A “tumor bank” provides a resource tool that can efficiently address the limitations of other tissue resources, such as clinical archives and research study collections. A tumor bank allows formal accreditatio...

    Linda Snell, Peter H. Watson in Breast Cancer Research Protocols (2006)

  17. Article

    Open Access

    Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis

    The human psoriasin (S100A7) gene has been implicated in inflammation and tumor progression. Implementation of a mouse model would facilitate further investigation of its function, however little is known of t...

    Meghan Webb, Ethan D Emberley, Michael Lizardo, Salem Alowami, Gefei Qing in BMC Cancer (2005)

  18. Article

    S100A7 and the progression of breast cancer

    The S100 gene family comprises more than 20 members whose protein sequences encompass at least one EF-hand Ca2+ binding motif. The expression of individual family members is not ubiquitous for all tissues and the...

    Ethan D Emberley, Leigh C Murphy, Peter H Watson in Breast Cancer Research (2004)

  19. Article

    S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situof the breast

    The S100A7 (psoriasin) gene is highly expressed in ductal carcinoma in situ (DCIS) of the breast and can be downregulated in invasive carcinoma. Persistent S100A7 expression in invasive carcinoma is associated wi...

    Ethan D Emberley, Salem Alowami, Linda Snell, Leigh C Murphy in Breast Cancer Research (2004)

  20. Article

    Mammographic density is related to stroma and stromal proteoglycan expression

    Mammographic density and certain histological changes in breast tissues are both risk factors for breast cancer. However, the relationship between these factors remains uncertain. Previous studies have focused...

    Salem Alowami, Sandra Troup, Sahar Al-Haddad, Iain Kirkpatrick in Breast Cancer Research (2003)

previous disabled Page of 2